Filter
4670
Text search:
drug
policy
Featured
Recommendations
388
New Publications
1251
Language
Document type
No document type
2818
Studies & Reports
734
Guidelines
555
Manuals
201
Strategic & Response Plan
170
Fact sheets
59
Training Material
53
Situation Updates
47
Infographics
11
Resource Platforms
9
Brochures
5
Online Courses
5
App
2
Countries / Regions
India
219
Global
160
Kenya
156
Uganda
118
South Africa
117
Western and Central Europe
108
Nigeria
105
Ethiopia
104
Nepal
92
Liberia
80
Sierra Leone
79
Tanzania
79
Malawi
79
Zambia
77
Myanmar / Burma
73
Ghana
71
Africa
69
Latin America and the Carribbean
67
Bangladesh
63
Eastern Europe
59
Namibia
56
Ukraine
54
Rwanda
53
Asia
43
Zimbabwe
42
Philippines
36
South–East Asia Region
36
Cambodia
35
Lesotho
35
Russia
33
Indonesia
32
Botswana
28
Mozambique
22
Eswatini/ Swaziland
22
Congo, Democratic Republic of
21
Senegal
19
Syria
19
Burkina Faso
18
East and Southern Africa
16
Brazil
15
West and Central Africa
13
Haiti
12
Colombia
12
Middle East and North Africa
12
Venezuela
12
Cameroon
11
Pakistan
11
South Sudan
11
Thailand
11
Eastern Europe and Central Asia
11
Guinea
10
Albania
10
Tajikistan
10
Georgia
10
Germany
9
Sudan
9
Vietnam
9
China
8
Afghanistan
7
Laos
7
Moldova
7
USA
6
Benin
6
North Macedonia
6
Sri Lanka
6
Yemen
6
Paraguay
6
Armenia
6
Peru
5
El Salvador
5
Mexico
5
Western Pacific Region
5
North America
5
Somalia
4
Iraq
4
Jordan
4
Central African Republic
4
Argentina
4
Libya
4
Timor Leste/ East Timor
4
Iran
4
United Kingdom
4
Lebanon
3
Turkey
3
Fiji
3
Bhutan
3
Palestine
3
Estonia
3
Kyrgyzstan
3
Jamaica
3
Mali
2
Côte d’Ivoire / Ivory Coast
2
Morocco
2
Saudi Arabia
2
Papua New Guinea
2
Serbia
2
Hungary
2
Bolivia
2
Chile
2
Poland
2
Southern Africa
2
Canada
2
Romania
2
Uzbekistan
2
Kazakhstan
2
Gabon
2
Belgium
2
Portugal
2
Belarus
2
Guinea-Bissau
1
Egypt
1
Gambia
1
Ireland
1
Dominican Republic
1
Switzerland
1
Honduras
1
Greece
1
Angola
1
Guatemala
1
Madagascar
1
Nicaragua
1
North Korea
1
Italy
1
Mongolia
1
Qatar
1
Bulgaria
1
Lithuania
1
Uruguay
1
Turkmenistan
1
Denmark
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Spain
1
Belize
1
Costa Rica
1
Panama
1
Authors & Publishers
Publication Years
Category
Countries
1871
Clinical Guidelines
360
Public Health
228
Women & Child Health
169
Key Resources
138
Capacity Building
55
Pharmacy & Technologies
51
Toolboxes
HIV
622
TB
515
Mental Health
418
AMR
248
COVID-19
167
Pharmacy
137
NTDs
122
NCDs
90
Malaria
86
Caregiver
82
Planetary Health
66
Ebola & Marburg
57
Global Health Education
56
Disability
53
Refugee
51
Conflict
46
Rapid Response
45
Health Financing Toolbox
43
Polio
24
2.0 Rapid Response
23
Natural Hazards
15
Specific Hazards
13
Cholera
10
Social Ethics
10
Zika
7
The intended purpose of this compendium is to provide program managers, organizations, and policy makers with a menu of indicators to better “know their HIV epidemic/know their response” from a gender perspective. The indicators in the compendiu
...
This updated implementation guidance is intended for all those who set policy for, or offer care to, pregnant women, families and infants: governments; national managers of maternal and child health programmes in general, and of breastfeeding- and
...
Antimicrobial resistance is one of the most important threats to the health worldwide. Antimicrobial resistance or drug resistance is the reduction of the pharmaceutical effects of a drug against a
...
WHO’s sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy is intended for easy and frequent implementation. Results from sentinel surveys provide insight into the prevalence and year-over-year trends of dolutegravir resi
...
From 2000 to 2010, Rwanda implemented comprehensive health sector reforms to strengthen the public health system, with the aim of reducing maternal and newborn deaths in line with Millennium Development Goal 5, among many other improvements in national health. Based on a systematic review of the lit
...
Recommendations for a Public Health approach and considerations for policy-makers and managers
There has been no systematic comparison of how the policy response to past infectious disease outbreaks and epidemics was funded. This study aims to collate and analyse funding for the Ebola epidemic and Zika outbreak between 2014 and 2019 in order
...
This resource aims to provide relevant and practical guidance to DRR practitioners (policy and programme colleagues), on how to ensure inclusion - particularly of vulnerable groups - in Community-Based DRR (CBDRR) initiatives in Myanmar. It comprise
...
Submission by the WHO Collaborating Centre on training and policy on opioid availability and WHO collaborating Centre for community participation in palliative care and long term care To the Indian Nursing Council for consideration to be included i
...
These guidelines provide specific recommendations and expert suggestions — for national policy-makers and programme managers and their partners and stakeholders— on prioritizing, planning and providing HIV testing, counselling, treatment and car
...
UN GUIDE POUR L’APPROVISIONNEMENTEN MÉDICAMENTS/ A guide for drug supply
Bochure in English and French
The use of Delamanid and Bedaquiline for Children with Drug-Resistant Tuberculosis.
Each year since 2007, G-FINDER has provided policy-makers, donors, researchers and industry with a comprehensive analysis of global investment into research and development of new products to
prevent, diagnose, control or cure neglected diseases in
...
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the dru
...
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging participation in the WHO Programme for International
...
The conduct of COVID-19 vaccine trials in the context of a candidate vaccine being issued with Emergency Use Designation raises challenging ethical questions, including in relation to the use of placebo controls and unblinding of trial participants in current and future COVID-19 vaccine trials. This
...
The primary role of Benin’s Department of Pharmacy and Medicines (DPMED) is to develop and apply the national pharmaceutical policy. The main objective of this policy is to ensure the availability
...
This guide is a resource for physicians and other health care professionals who provide care and treatment to patients with drug-resistant tuberculosis.
The "Global NCD action plan" provides a road map and a menu of policy options for countries to take in order to attain the 9 voluntary global targets, including that of a 25% relative reduction in premature mortality from cardiovascular diseases, ca
...
The Access to Controlled Medications Programme identified the development of treatment guidelines that cover the treatment of all types of pain as one of the core areas of focus for improving access to opioid analgesics. Such guidelines are interesting both for health-care professionals and
...
